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Abstract
Chronic high glucose (HG) inflicts glucotoxicity on vulnerable cell types such as pancreatic b cells and contributes to insulin
resistance and impaired insulin secretion in diabetic patients. To identify HG-induced cellular aberrations that are candidate
mediators of glucotoxicity in pancreatic b cells, we analyzed gene expression in ERoSHK6, a mouse insulin-secreting cell line
after chronic HG exposure (six-day exposure to 33.3 mM glucose). Chronic HG exposure which reduced glucose-stimulated
insulin secretion (GSIS) increased transcript levels of 185 genes that clustered primarily in 5 processes namely cellular
growth and proliferation; cell death; cellular assembly and organization; cell morphology; and cell-to-cell signaling and
interaction. The former two were validated by increased apoptosis of ERoSHK6 cells after chronic HG exposure and
reaffirmed the vulnerability of b cells to glucotoxicity. The three remaining processes were partially substantiated by
changes in cellular morphology and structure, and instigated an investigation of the cytoskeleton and cell-cell adhesion.
These studies revealed a depolymerized actin cytoskeleton that lacked actin stress fibers anchored at vinculin-containing
focal adhesion sites as well as loss of E-cadherin-mediated cell-cell adherence after exposure to chronic HG, and were
concomitant with constitutive ERK1/2 phosphorylation that was refractory to serum and glucose deprivation. Although
inhibition of ERK phosphorylation by PD98059 promoted actin polymerization, it increased apoptosis and GSIS impairment.
These findings suggest that ERK phosphorylation is a proximate regulator of cellular processes targeted by chronic HG-
induced gene expression and that dynamic actin polymerization and depolymerization is important in b cell survival and
function. Therefore, chronic HG alters gene expression and signal transduction to predispose the cytoskeleton towards
apoptosis and GSIS impairment.
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Introduction
Diabetes mellitus is an epidemic metabolic disease with mild
early symptomatic manifestations that as a result of poor disease
management, often lead to severe complications such as cardio-
vascular disease, limb amputation, diabetic retinopathy, renal
failure, diabetic neuropathy (http://www.who.int/topics/
diabetes_mellitus/en/; accessed August 2011). Type 2 (or non-
insulin-dependent or adult-onset) diabetes (T2D) which is the
more prevalent form, is caused by reduced insulin release,
peripheral insulin resistance, and insulin failure to suppress
glucose production [1]. The pathophysiology of diabetic compli-
cations is a complex multifactorial process that ensues primarily
from hyperglycemia, and targets vulnerable cells such as capillary
endothelial cells in the retina, mesangial cells in the renal
glomerulus, neurons and Schwann cells in peripheral nerves [2],
and pancreatic b cells. Clinical studies have demonstrated that
hyperglycemia toxicity causes deterioration of pancreatic b cell
mass and function leading to the progression of diabetes and
development of diabetic complications in diabetic patients [3,4,5]
[reviewed by Wajchenberg [6]]. The vulnerability of pancreatic b
cells and other diabetes-associated cell types to hyperglycemia-
induced tissue toxicity (or glucotoxicity) has been attributed to
their inability to reduce glucose uptake when exposed to
hyperglycemia [2]. Excessive glucose uptake has been shown to
induce biochemical changes such as increased flux through the
polyol pathway, enhanced production of advanced glycation end
products (AGEs), activation of PKC, and increased activity of the
hexosoamine pathway [2]. These biochemical changes have the
potential to increase reactive oxygen species production and to
modify proteins and lipids that could result in global cellular
damage and severe phenotypic alterations such as mitochondria
dysfunction [7], endoplasmic reticulum stress [8], increased
intracellular calcium and cell death [9]. However, the progression
from these glucotoxicity-induced cellular damages to deterioration
or loss of specific b cell functions such as loss of glucose sensitivity
and impairment of glucose-stimulated insulin secretion (GSIS),
[10,11,12,13,14] and ultimately b cell apoptosis [15,16,17],
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remains poorly characterized. Since b cell dysfunction has been
shown to be central to the development and progression of T2D
[18], timely interventional therapies to preserve the important b
cell function of GSIS and viability are likely to improve the
prognosis of the disease [19,20].
In view of the multiple reported effects of hyperglycemia on b
cells, we attempted to expand the current understanding through
gene expression profiling to identify cellular changes that are
induced by exposure to high glucose. We employed mouse ESC-
derived insulin-producing ERoSHK6 cells as a surrogate b cell
model for this study. This clonal and highly scalable cell line
displays the defining functional properties of bona fide pancreatic
b cells. ERoSHK6 cells synthesize and store insulin in typical
intracellular vesicles. Under stimulation by secretagogues such as
glucose, tolbutamide and glibenclamide, these cells close their
ATP-sensitive K+ channels, leading to membrane depolarization,
opening of Ca2+ channels and the subsequent release of insulin
and C-peptide in equimolar ratio, a mechanism resembling that of
primary b cells. Most importantly, these cells can reverse
hyperglycemia when grafted into streptozotocin-treated mice
[21]. ERoSHK6 cells also exhibit biochemical pathways that are
highly characteristic of b cells, such as the pentose phosphate
pathway, clathrin-mediated endocytosis and peroxisome prolif-
erator-activated receptor (PPAR) signaling pathway [22].
ERoSHK6 cells are ideal for investigating the effects of chronic
hyperglycemia on pancreatic b cells not only for their close
resemblance to b cells but also for their capacity to be propagated
in culture for extended periods, unlike primary b cells.
To assess the effect of chronic exposure to high glucose on gene
expression, ERoSHK6 cells were exposed to HG (33.3 mM) for
six days. This exposure reduced GSIS and analysis of the cellular
RNA by hybridization of a microarray of gene probes identified
185 genes that are highly upregulated in HG-treated ERoSHK
cells. These genes were involved primarily in regulating cell
structure and survival. In concordance with our microarray
analysis, we observed that high glucose led to increased apoptosis
and changes in ERoSHK colony morphology, depolymerisation of
actin and loss of E-cadherin-mediated cell-cell contact. Together,
these observations implicated the cytoskeleton as a major target of
HG-mediated cellular aberrations.
The critical role of the cytoskeleton in stimulated insulin
secretion by pancreatic b cells has long been recognized
[23,24,25]. Insulin exocytosis has been observed to occur via at
least three different modes of granule fusion with the plasma
membrane. One mode is fusion with pre-docked granules, the
second is the immediate fusion of newly recruited granules to the
plasma membrane and the third mode is fusion with newly
recruited and docked granules [26]. Insulin exocytosis has also
been shown to occur via partial fusion with the plasma membrane
(termed ‘‘kiss-and-run exocytosis’’) [27,28]. Irrespective of the
mode of granule fusion with the plasma membrane, the physical
execution of GSIS in pancreatic b cells requires dynamic and
transient remodeling of the cytoskeleton to move secretory vesicles
to the inner surface of the plasma membrane, dock the granules
and exocytose the contents of the granules by membrane fusion
and fission [29,30] It has been observed that depolymerization and
polymerization of F-actin are necessary to execute GSIS. For
example, F-actin depolymerisation has been shown to enhance
GSIS in MIN6 b cells [31] while inhibition of RhoGDI which
activates Cdc42 to promote actin polymerization led to increased
GSIS [32,33]. These diametrical observations could be reconciled
by the need to alternate between polymerized and depolymerized
F-actin cytoskeleton to move, dock and fuse secretory vesicles for
GSIS, and a predilection for either a polymerized or depolymer-
ized state would compromise GSIS. Incidentally, an alternating
actin polymerization and depolymerization has been shown to be
important in cellular survival [reviewed in [34]]. This need to
maintain a stimuli-responsive cytoskeleton connotes an exquisitely
regulated cytoskeleton in pancreatic b cells. Indeed, many
cytoskeletal components e.g. focal adhesions [35], F-actin
[24,36,37,38,39,40], and regulatory small G proteins e.g. Cdc42
and Rac1 [41,42,43] have been implicated in the regulation of
insulin secretion.
This study also implicated ERK signaling in HG-induced
changes in ERoSHK colony morphology, depolymerisation of
actin and the loss of E-cadherin-mediated cell-cell contact. HG-
induced ERK activation was found to be sustained and refractory
to serum starvation, and therefore not likely to be compatible with
the dynamic actin polymerization and depolymerization necessary
for the execution of GSIS and cellular survival. ERK1/2
phosphorylation which is downstream of MAPK signaling has
been associated with actin cytoskeleton remodeling, focal adhesion
remodeling and GSIS [31,44]. The role of ERK1/2 in b cell
function has been implicated in diametrical processes and remains
to be clarified. For example, glucose-induced ERK1/2 phosphor-
ylation has been implicated in the long term deleterious effects of
high glucose on b cell, namely apoptosis and impaired insulin
secretory function [45] while adiponectin- or insulin-induced
ERK1/2 phosphorylation improves cell survival and insulin
secretory function [46,47].
Results
High glucose impaired insulin secretion in ERoSHK6 cells
To determine if chronic high glucose was detrimental to
ERoSHK6 cells, the cells were cultured in INS medium
containing either LG or HG. Cells exposed to 6 days of LG or
HG treatment will hereafter be referred to as ERoSHKLG or
ERoSHKHG respectively. Since HG is known to cause b cell
dysfunction, we assessed insulin secretion by ERoSHKLG and
ERoSHKHG. Relative to ERoSHKLG, basal insulin secretion of
ERoSHKHG when assayed in the presence of 2.8 mM glucose was
increased by 43.70% (P,0.001) while its glucose stimulated insulin
secretion (GSIS) as assayed in the presence of 16.7 mM glucose
was reduced by 36.33% in ERoSHKHG (P,0.005) (Fig. 1).
Figure 1. High glucose impaired insulin secretion in ERoSHK.
Insulin secretion of ERoSHKLG and ERoSHKHG in response to 2.8 mM
(basal) and 16.7 mM (stimulated) glucose, expressed as a percentage of
total insulin content. Data are presented as mean 6 s.d.; n = 3. *,
P,0.005; **, P,0.001.
doi:10.1371/journal.pone.0044988.g001
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Changes in gene expression of ERoSHKHG cells targeted
cell survival and structure
For a better understanding of hyperglycemia-induced cellular
changes that result in b cell dysfunction and death, we studied the
global gene expression profile of ERoSHKLG and ERoSHKHG by
hybridizing labeled cRNA to Illumina BeadArray containing
about 25,700 unique features. After filtering out genes with
detection values below the confidence level of 95%, we detected
the expression of 6628 genes in ERoSHKLG versus 6680 genes in
ERoSHKHG. Of these, 6495 genes were expressed at similar levels
(,2.0-fold difference) between the two samples. ERoSHKHG up-
regulated the expression of 185 genes as compared to
ERoSHKLG, based on a fold-change cut-off of $2.0 (Figure 2A,
list of genes in Table S2). These 185 genes highly expressed in
ERoSHKHG were analyzed by Ingenuity Pathway Analysis
(Ingenuity Systems), which clustered the genes based on their
cellular functions. The 5 most significant cellular functions
(P,0.05) are: (1) cellular assembly and organization; (2) cellular
growth and proliferation [38]; (3) cell death; (4) cell morphology;
and (5) cell-to-cell signaling and interaction (Fig. 2B). The genes
that are over-represented in these cellular functions can be found
in Table S3. To further validate these results from microarray
analysis, the expression levels of a random sample of 10 genes (two
from each of these five significant cellular processes) were
evaluated by qPCR. The 10 genes were Actn2 and Tpm2 involved
in cellular assembly and organization; Cdkn1a and Wnt5a involved
in cellular growth and proliferation; Dapk2 and Ppargc1a involved
in cell death; Mylip and Ninj2 involved in cell morphology; and
Cd97 and Ephb3 involved in cell-to-cell signaling and interaction.
Of the ten genes, 8 genes were indeed upregulated by more than
2.0-fold in ERoSHKHG as compared to ERoSHKLG, in concor-
dance with the microarray analysis (Fig. 2C).
HG inhibited population growth by increased apoptosis
with no significant effect on rate of cell division
Cellular growth and proliferation, and cell death were two of
five most significant cellular functions that were computationally
predicted to be modulated by the HG-induced changes in gene
expression. Consistent with these predictions, viable cell popula-
tion for ERoSHKLG and ERoSHKHG increased 6.7- and 5.5-fold
respectively (P,0.001) (Fig. 3A). The first significant difference
occurred at day 6. To ascertain if this difference was due to
reduced cell division or increased apoptosis, the rate of cell division
in ERoSHKLG and ERoSHKHG at day 6 and onwards was
determined by labeling cells with CFSE and monitoring cellular
fluorescence over 72 hours by flow cytometry. Assuming that
cellular fluorescence was halved at each cell division, the number
of cell division over time could be calculated as a function of loss in
cellular fluorescence as described in Materials and Methods. The
mean number of cell divisions per 24 h over a period of 72 h post-
treatment for ERoSHKLG and ERoSHKHG were not significantly
different at 0.93 versus 0.90 (P.0.05) (Fig. 3B), while the average
duration of each cell division was 26.12 h versus 25.52 h
respectively (Fig. S1). Therefore the reduced population growth
in ERoSHKHG cells was not due to reduced cell division but
possibly increased cell death. Annexin V staining of ERoSHKLG
and ERoSHKHG cells revealed that apoptosis was consistently
higher in ERoSHKHG (Fig. 3C). Although this increase was small,
it was highly significant (P,0.001). This was further corroborated
by cellular DNA content analysis. Relative to ERoSHKLG,
ERoSHKHG was arrested in G2/M arrest with less cells in G0/
G1 phase (49.77% to 46.35%, P,0.005) and S phase (13.20% to
12.22%, P,0.005) but more in G2/M phase (37.03% to 41.44%,
P,0.001). Consistent with the increased Annexin V-positive
ERoSHKHG cells, there was also more cellular debris in
ERoSHKHG culture as represented by the sub-G0 fraction
(1.11% to 2.96%, P,0.001) (Fig. 3D, upper panel). These
differences were maintained over the following 3 days (Fig. 3D,
lower panel). Together, these observations indicated that HG
reduced population growth of ERoSHK6 cells by inducing G2/M
arrest and increasing apoptosis, without inhibiting the rate of cell
division.
ERoSHKHG displayed altered cell morphology,
disorganized actin cytoskeleton and reduced cell-cell
adhesion
The computational prediction that the 185 genes highly
expressed in ERoSHKHG were involved in cellular assembly and
organization, cell morphology and cell-to-cell signaling and
interaction suggested that ERoSHKHG would be morphologically
different from ERoSHKHG. Further, as execution of these
functions would all require modulation of the cytoskeleton and
cellular adhesion, we speculated that the cytoskeleton and cellular
adhesion structural changes in ERoSHKHG were also modulated
by chronic HG treatment.
Consistent with the computational prediction and its attendant
implications, ERoSHKHG colonies and cells were manifestly
different from those of ERoSHKLG which like MIN6 mouse
pancreatic b cell line [48] grew in tightly packed colonies with
close cell-cell contact. In contrast, ERoSHKHG formed smaller
colonies of loosely packed cells with reduced cell-to-cell contact
(Fig. 4A). To assess the role of cytoskeletal organization and
adhesion molecules in mediating this altered cellular morphology,
both ERoSHKLG and ERoSHKHG were stained with fluores-
cence-tagged phalloidin and antibodies against E-cadherin.
Consistent with the tightly packed cells in ERoSHKLG colonies,
adjacent cells within each colony shared common boundaries
demarcated by E-cadherin (Fig. 4B). Staining with fluorescence-
tagged phalloidin and antibodies against vinculin further revealed
that the basement actin cytoskeleton in many of the ERoSHKLG
cells had F-actin stress fibers anchored at focal adhesion sites as
indicated by vinculin. In contrast, many ERoSHKHG cells within
a colony did not share a common boundary with their neighbours
and were physically separated by distinctly visible gaps between
the E-cadherin demarcated membranes, indicating reduced cell-
cell adhesion. Many of the ERoSHKHG also did not display the
focal adhesion-anchored F-actin stress fibers (Fig. 4C).
Sustained high levels of ERK signaling in ERoSHKHG
Glucose is known to activate ERK1/2 in b cells during GSIS
[49,50,51], and ERK1/2 activation has been implicated in actin
cytoskeletal remodeling [31,35,52]. In addition, our gene expres-
sion analysis revealed that a factor reported to be involved in the
activation of ERK, TNIP2 (ABIN-2) [53] was upregulated by HG.
To determine if ERK signaling played a role in the cytoskeletal
modifications during chronic high glucose exposure, pERK1/2
levels in ERoSHKLG cells and ERoSHKHG were assayed and
were found to be comparable (Fig. 5A, left panel). However, we
observed that 2, 4 and 8 hours of serum starvation, which
expectedly abrogated ERK1/2 phosphorylation in ERoSHKLG
cells, failed to do so in ERoSHKHG suggesting that ERK1/2
phosphorylation was refractory to downregulation by serum
starvation and possibly to other regulatory controls, and
ERoSHKHG cells had constitutively active ERK signaling
(Fig. 5A, right panel). As a consequence of the relatively high
basal pERK1/2 level, glucose stimulation enhanced pERK1/2
Glucotoxicity Inhibits Cytoskeletal Dynamism
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Figure 2. High glucose enhanced the expression of genes that regulate cell survival and structure in ERoSHK. a Scatter plot was
created using Illumina BeadStudio, to display the 6813 genes expressed by both ERoSHKLG and ERoSHKHG and their average detection signal on
logarithmic scales. Dashed lines represent 2.0-fold difference boundaries and grey dots represent the 185 genes up-regulated by ERoSHKHG. b The
185 up-regulated genes were uploaded onto Ingenuity Pathway Analysis, and over-represented in 23 molecular and cellular functions with P,0.05
(dashed line). The top 5 most significant functions are represented by black bars. c Expression levels of 10 randomly selected genes, 2 from each of
the top 5 most significant functions, as determined by quantitative PCR. Transcript levels are first normalized to Actb endogenous control, and then
to those of ERoSHKLG. Data are presented as mean 6 s.d.; n = 3.
doi:10.1371/journal.pone.0044988.g002
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Figure 3. HG inhibited population growth by increased apoptosis with no significant effect on rate of cell division. a Cells were
cultured in LG or HG conditions and total number of viable cells was quantified each day as determined by Guava Viacount assay. Data are
normalized to the number of cells seeded on day 0, and represented as mean 6 s.d.; n = 3. *, P,0.001. b ERoSHK cells pretreated with LG and HG for
6 days were stained with CFSE and the rate of loss of fluorescence signal was monitored over 72 h by flow cytometry. The number of divisions per
24 h during the 72 h period after 6 days of LG and HG treatment is graphically represented (mean6 s.d.; n = 3). c Left panel, ERoSHKLG and ERoSHKHG
were stained with phycoerythrin-conjugated Annexin V and dye fluorescence was measured by flow cytometry. The gates on scatter plots of side-
scatter (SSC) versus phycoerythrin fluorescence intensity represent Annexin V-positive cells. Right panel, percentages of Annexin V-positive cells were
Glucotoxicity Inhibits Cytoskeletal Dynamism
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assessed daily over a period of 72 h and graphically represented. Data are presented as mean 6 s.d.; n = 3. *, P,0.001. d Upper panel, ERoSHKLG and
ERoSHKHG were fixed, stained with propidium iodide (PI) and dye fluorescence was measured by flow cytometry. Histogram plot of cell number
versus PI fluorescence intensity was deconvoluted using ModFit LT software. Percentage of cells in each phase of the cell cycle is depicted above their
respective peaks. Lower panel, the experiment was further repeated 24, 48 and 72 h post treatment and percentages of cells in the different cell cycle
phases are graphically represented. Data are presented as mean 6 s.d.; n = 3. *, P,0.05; **, P,0.005; ***, P,0.001.
doi:10.1371/journal.pone.0044988.g003
Figure 4. High glucose altered cell morphology, disrupted actin organization and reduced cell-cell adhesion in ERoSHK. a
Representative phase contrast images of ERoSHKLG and ERoSHKHG showing changes in colony morphology. Scale bars, 100 mm. b
Immunofluorescence staining for E-cadherin (green) in ERoSHKLG and ERoSHKHG. Cells were counterstained with phalloidin (red) for F-actin and
DAPI (blue) for nuclei. White arrowheads indicate sites of membrane separation. Parts of the merged image (box with white dashed lines) are
magnified in the right panels to clearly visualize the co-localization of E-cadherin and cortical actin along the cell periphery, as well as gaps between
adjacent cells. Scale bars, 10 mm. c Immunofluorescence staining for vinculin (green) in ERoSHKLG and ERoSHKHG. Cells were counterstained with
phalloidin (red) for F-actin and DAPI (blue) for nuclei. White arrowheads indicate actin stress fibers at the basal membrane. Scale bars, 10 mm.
doi:10.1371/journal.pone.0044988.g004
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level by 6.4262.50-fold in ERoSHKLG that were serum-starved
for 2 hours (P,0.05). In serum-starved ERoSHKHG, the increase
was not significant at 1.1860.20-fold (P.0.05) (Fig. 5B).
Abrogation of ERK signaling in ERoSHKHG restored colony
morphology, actin cytoskeletal disruption and loss of
cell-cell contact
The constitutively active pERK level in ERoSHKHG and the
documented role of pERK in the regulation of actin cytoskeleton
[31,35,52] suggested that aberrant ERK signaling could be
responsible for the disorganized actin cytoskeleton, loss of cell-
cell adhesion and other changes in colony morphology of
ERoSHKHG. To test this hypothesis, ERoSHK6 cells were
cultured in LG or HG in the absence and presence of PD98059,
a specific pharmacological inhibitor of MEK1/2 which phosphor-
ylates ERK1/2 kinase [54]. To optimize the dose concentration of
the inhibitor, we tested several inhibitor concentrations and
determine that the lowest concentration required to reverse
morphological changes in HG-treated cells was 25 mM. At this
concentration, the inhibitor reduced ERK phosphorylation in
both ERoSHKLG and ERoSHKHG from a similar pERK/ERK
ratio (Fig. 5A) to the same level (Fig. 6A). The actin cytoskeleton of
PD98059-treated ERoSHKHG cells reverted to that of
ERoSHKLG cells with stress fibers anchored by focal adhesion
sites while PD98059-treated ERoSHKLG cells remained pheno-
typically similar to ERoSHKLG (Fig. 6B). PD98059 also increased
cell-cell contact within ERoSHKHG colonies. PD98059-treated
ERoSHKHG cells were tightly packed within each colony and
adjacent cells share common boundaries delineated by E-cadherin
and cortical actin staining by rhodamine-phalloidin with no visible
gaps between cells. Both PD98059-treated ERoSHKLG and
ERoSHKHG resembled ERoSHKLG (Fig. 7A). These cytoskeletal
changes were also consistent with a change in the gross colony
morphology of ERoSHKHG to that of ERoSHKLG (Fig. 7B).
However, the rate of apoptosis in PD98059-treated ERoSHKHG
was not reduced to that in ERoSHKLG or PD98059-treated
ERoSHKLG and remained high as in ERoSHKHG (Fig. 7C). We
observed that 5 mM PD98059 was sufficient to induce significant
apoptosis in ERoSHKHG (Fig. S2). GSIS was also attenuated in
both PD98059-treated ERoSHKLG and ERoSHKHG, at levels
similar to ERoSHKHG (Fig. 7D).
Discussion
Metabolic overload of islets from chronic exposure to elevated
level of nutrients (e.g. glucose) has been postulated to be important
in the pathogenesis of T2D [55] and this importance is best
evidenced by the effectiveness of meticulous glycemic control in
slowing progression to diabetes and reducing the risk of
microvascular and neurological complications of diabetes [56].
In pre-T2D patients, normoglycemia could be maintained as long
as insulin resistance is adequately compensated by increased
insulin secretion. When this b cell compensation is abrogated by b
cell dysfunction and loss of b cell mass through apoptosis, T2D
ensues with a fasting blood glucose level exceeding 5.5 mM. This
ensuing hyperglycemia causes glucotoxicity and b cell phenotypic
alterations to further exacerbate b cell dysfunction and increase
apoptosis [18].
Over the years, multiple mechanistic models for the detrimental
effects of hyperglycemia on the b cell have been proposed. In this
study, we analysed global gene expression profiles of low and high
glucose-treated ERoSHK6 cells as an unbiased approach to
Figure 5. High glucose induced sustained ERK phosphorylation in ERoSHK. a Left panel, relative levels of phosphorylated ERK1/2 total
ERK1/2 in ERoSHKLG and ERoSHKHG were analyzed by western blotting. Right panel, ERoSHKLG and ERoSHKHG were pre-incubated in KRBH buffer
containing 0.1% BSA for 2, 4 and 8 h before being treated with or without a 10 mM glucose stimulation for 10 min. Relative levels of phosphorylated
ERK1/2 and total ERK1/2 were then analyzed by western blotting. b 3 independent ERK phosphorylation assays were performed on ERoSHKLG and
ERoSHKHG serum-starved for 2 h. The relative intensities of phosphorylated (P) and total ERK protein bands were quantified by densitometry and
expressed as a ratio (P-ERK/ERK), normalized to that of unstimulated ERoSHKLG cells. Data are presented as mean 6 s.d.; n = 3. *, P,0.05.
doi:10.1371/journal.pone.0044988.g005
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Figure 6. Inhibition of ERK phosphorylation in ERoSHKHG restored actin cytoskeleton organization. a Upper panel, ERoSHK cells were
cultured in LG or HG in the absence and presence of 25 mM of PD98059 for 6 days. Cells were lysed and relative amounts of phosphorylated ERK and
total ERK were analyzed by western blotting. Lower panel, P-ERK/ERK ratios normalized to ERoSHKLG. Intensities of protein bands were quantified by
densitometry. b Cells were fixed, immunostained for vinculin (green) and counterstained with phalloidin (red) for F-actin and DAPI (blue) for nuclei.
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identify high glucose-induced cellular aberrations that are
candidate mediators of glucotoxicity in pancreatic b cells.
ERoSHK6 is a clonal mouse embryonic stem cell-derived line
that exhibits the salient functional features of pancreatic b cells in
insulin production and secretion as described in the Introduction.
Unlike primary islets or pancreatic b cells, ERoSHK6 cells are
more amenable to long-term culture without compromising their b
cell-like functions and are more suitable for assessing the effects of
chronic high glucose exposure. As demonstrated by our study,
these cells also exhibited a typical b cell dysfunction when exposed
to chronic high glucose, i.e. impairment of GSIS
[10,11,12,13,14,57,58]. The impairment of GSIS by chronic
hyperglycemia is well documented [reviewed by [59]] in patients
[60], animals [61,62], isolated islets [63,64] and b cell lines
[14,65,66]. After exposure to chronic high glucose, ERoSHKHG
exhibited a substantial increase in basal secretion and concomitant
reduction in GSIS consistent with the observations of a previous
study using rat islets treated with high glucose for 1 week [64]. In
addition, unlike others who reported a 20 to 50% apoptosis in
pancreatic b cells within 4–6 days of exposure to high glucose
[67,68,69], we observed a low but significant increase in apoptosis
from 8.01 to 10.94% only after 6 days of treatment. This slower
and smaller increase in apoptosis is more consistent with the slow
progressive loss in b cell function and b cell mass from apoptosis
during T2D pathogenesis.
Comparative analysis of the genome-wide gene expression
profile of ERoSHKLG and ERoSHKHG cells revealed that
ERoSHKHG cells increased expression of genes predominantly
involved in modulating cellular functions such as cellular assembly
and organization, cellular growth and proliferation, cell death, cell
morphology, and cell-to-cell signaling and interaction. The
inclusion of cellular growth and proliferation, and cell death as
two of the five most significantly modulated processes by glucose-
induced genes was consistent with the well documented effects of
glucotoxicity and validated our use of global gene expression to
identify candidate cellular functions that are triggered by high
glucose. Of the remaining three most significantly modulated
processes, it is notable that the common denominator is the
involvement of cytoskeleton-mediated structure and this was
consistent with the structural abnormalities that have been
observed in isolated islets from T2D cadaveric donors [70].
Although the effects of glucose on the modulation of cytoskel-
eton during insulin secretion have been extensively studied, they
have been largely limited to transient glucose stimulation. Little is
known about the effects of chronic high glucose on the
cytoskeleton of insulin-producing cells.
In this study, we observed that morphological changes in cell
shape and colony phenotype were early definitive manifestations
of high glucose exposure. Cells within each colony lost their tightly
packed arrangement and separated from each other with distinct
gaps between adjacent cells in the colony. These changes in colony
and cell morphology were underpinned by changes in the actin
cytoskeleton, focal adhesion and cell-cell interaction through E-
cadherin. Unlike ERoSHKLG colonies where adjacent cells within
each colony shared common boundaries demarcated by E-
cadherin, many cells in ERoSHKHG colonies were physically
separated from each other by distinctly visible gaps between
plasma membranes. The gaps between E-cadherin demarcated
plasma membranes suggested that high glucose caused disengage-
ment of homotypic E-cadherin interactions. E-cadherin is a cell
adhesion molecule and homotypic E-cadherin interactions are
important in the aggregation of b cells during islet development in
mice [71] or MIN6 pseudoislets. Our observations of disrupted E-
cadherin interaction between neighbouring ERoSHKHG cells also
implicated for the first time the role of hyperglycemia in disrupting
gap junctional communication not only in T2D vulnerable cell
types such as vascular smooth muscle, endothelial cells, retinal
pericytes and astrocytes [72,73,74,75,76,77,78] but also in
pancreatic islets. The importance of E-cadherin in maintaining
junctional communication for b cell function has been previously
demonstrated by a reduction in GSIS upon down-regulation of E-
cadherin in confluent MIN6B1 cell monolayer [79]. Maintaining a
tight cell-cell contact of b cells in the islets of Langerhans is also
important in forming a syncytium to facilitate the propagation and
synchronization of the stimulus-secretion response through the
islet via intercellular electrical coupling of membrane depolariza-
tion and movement of small signal molecules and ions through
tight gap junctions [80,81] that is crucial in mounting a prompt
and appropriate first-phase insulin response to nutrient stimuli
[82,83]. This detrimental effect of hyperglycemia on b cell
connectivity is consistent with the well documented ‘‘diabetic
isletopathy’’ phenotype in hyperglycemic T2DM patients or
rodent models of T2DM [84,85,86]. One of the earliest
ultrastructural changes in diabetic isletopathy is the loss of
adherens junctions and desmosomes, and this loss precedes
remodeling fibrosis and islet amyloid deposition [87]. Therefore,
the reduced E-cadherin interaction leading to loss of tight cell-cell
junction in ERoSHKHG cells represented a mechanism by which
GSIS in diabetic patients could be compromised by hyperglyce-
mia.
Staining with fluorescence-tagged phalloidin and antibody
against vinculin revealed that unlike ERoSHKLG cells which
had basement F-actin stress fibers anchored at vinculin-stained
focal adhesion sites, ERoSHKHG cells displayed a disorganized
actin cytoskeleton that was no longer anchored at focal adhesion
sites. Cortical actin organization in both ERoSHKLG and
ERoSHKHG cells was, however morphologically similar. As
dispersed pancreatic b-cells which exhibit similar alterations in
actin cytoskeleton were reported to have constitutive ERK
phosphorylation [79], we investigated ERK1/2 phosphorylation
which is downstream of MAPK signaling and has been associated
with actin cytoskeleton remodeling, focal adhesion remodeling and
GSIS [31,44]. ERoSHKHG cells were found to have constitutively
phosphorylated ERK1/2 and this phosphorylation was refractory
to serum deprivation. Inhibition of ERK1/2 phosphorylation by
PD98059 reverted the altered actin cytoskeleton, focal adhesions
and cell-cell contact in ERoSHKHG cells to that of ERoSHKLG
cells. These observations suggested that while HG altered gene
expression to support cytoskeletal modification, HG-induced
ERK1/2 phosphorylation was a more proximate regulator of
the cytoskeleton. The reversal of glucose-induced cytoskeletal
abnormalities by PD98059 however did not reverse glucose-
induced cell death and impairment of GSIS in ERoSHKHG.
Instead, cell death and impaired GSIS worsened in both
ERoSHKHG and ERoSHKLG cells. This PD98059-mediated cell
death and GSIS impairment were consistent with previous reports
of its role in inhibiting CREB phosphorylation and initiation of
apoptosis [88] and in mediating GLP1-potentiation of GSIS [89].
This perplexing failure of PD98059 to reverse either cell death or
impaired GSIS in ERoSHKHG cells could be attributed to the
involvement of ERK1/2 phosphorylation in diametrically oppos-
ing cellular functions. For example, glucose-induced ERK1/2
White arrowheads indicate actin stress fibers at the basal membrane. Scale bars, 10 mm.
doi:10.1371/journal.pone.0044988.g006
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phosphorylation has been implicated in the long term deleterious
effects of high glucose on b cell, namely apoptosis and impaired
insulin secretory function [45] while adiponectin- or insulin-
induced ERK1/2 phosphorylation improves cell survival and
insulin secretory function [46,47]. Therefore, ERK1/2 phosphor-
ylation in b cell could be context-dependent, such that phosphor-
ylation in one context leads to regulation of the cytoskeleton while
in another context leads to apoptosis and/or GSIS. As such, a
global inhibition of ERK1/2 phosphorylation by PD98059 would
obscure any context-dependent phosphorylation. One strategy to
assess this hypothesis may be to identify the different proteins in
the ERK1/2 interactome and determine if ERK1/2-mediated
regulation of the cytoskeleton operates through a different
signaling cascade of proteins from that of apoptosis or GSIS. If
so, it will also support a corollary of this hypothesis that HG-
mediated cytoskeletal regulation is decoupled from HG-mediated
apoptosis and/or GSIS. However, this would contradict the well-
established links between cytoskeleton and GSIS or cytoskeleton
and apoptosis.
The critical role of cytoskeleton in stimulated insulin secretion
by pancreatic b cells was recognized in the early 1970s [23,24].
Like all secretory cells, the physical execution of GSIS in
pancreatic b cells involves dynamic modulation of the cytoskeleton
to move secretory vesicles to the inner surface of the plasma
membrane for docking and exocytotic membrane fusion and
fission [29]. As such, the cytoskeleton is highly regulated and many
components of the cytoskeleton such as focal adhesions [35], F-
actin [24,36,37,38,39,40], and regulatory small G proteins e.g.
Cdc42 and Rac1 [41,42,43] have been implicated in the
regulation of insulin secretion.
To reconcile our hypothesis that HG-mediated cytoskeletal
regulation is decoupled from HG-mediated apoptosis and/or
GSIS with the well-established links between cytoskeleton and
GSIS or cytoskeleton and apoptosis, we note that stimulated
secretion in many secretory cell types correlates with transient
depolymerisation of the actin network [30,40,44,90,91]. Transient
remodeling of F-actin cytoskeleton helps mobilize granules to be
docked at the plasma membranes [92] and facilitate access of
docked insulin granules to the plasma membrane [41,44]. It has
been observed that F-actin undergoes both depolymerization and
polymerization during GSIS. For example, F-actin depolymerisa-
tion has been shown to enhance GSIS in MIN6 b cells [31] while
inhibition of RhoGDI which activate Cdc42 to promote actin
polymerization led to increased GSIS [32,33]. These observations
suggest that the F-actin cytoskeleton alternates between polymer-
ization and depolymerization to move, dock and fuse secretory
vesicles for GSIS, and a predilection for either a polymerized or
depolymerized state would compromise this alternation. Inciden-
tally, an alternating actin polymerization and depolymerization
has also been shown to be important in cellular survival [reviewed
in [34]]. This requisite for a dynamic cytoskeleton alternating
between polymerized and depolymerized provides a rationale for
our observations that GSIS and cell survival remained compro-
mised in both ERoSHKHG with a depolymerized F-actin
cytoskeleton and in PD98059-treated ERoSHKHG with a poly-
merized F-actin cytoskeleton.
In conclusion, our approach of using an unbiased global gene
expression analysis to uncover candidate b cell functions affected
by chronic high glucose exposure re-affirmed the vulnerability of
insulin-secreting cells to glucotoxicity and implicated the role of
the cytoskeleton in b cell survival and stimulated insulin secretion.
Our study also suggested a unifying model linking the cytoskeleton
with stimulated insulin secretion and b cell survival. We propose
that HG, through modulation of gene expression and ERK1/2
signal transduction, predisposed the actin cytoskeleton in b cells
towards a constitutively depolymerized state and compromised the
dynamic equilibrium between polymerization and depolymeriza-
tion of the actin cytoskeleton, resulting in defective stimulated
insulin secretion and decreased b cell survival. While inhibition of
ERK1/2 signal transduction by PD98059 reversed the actin
cytoskeleton towards a constitutively polymerized state, it cannot
restore the dynamic equilibrium between polymerization and
depolymerization of the actin cytoskeleton, and therefore cannot




Insulin-producing ERoSHK6 cells were derived from mouse
embryonic stem cells and cultured as described previously [21]. To
investigate the effects of chronic HG exposure as opposed to low
glucose (LG) exposure, ERoSHK6 cells were first pre-incubated in
INS medium containing 11.1 mM glucose for 24 h, followed by a
medium change to one containing either LG (defined as 11.1 mM
glucose) or HG (defined as 33.3 mM glucose), and the medium
was refreshed every 2 days.
Insulin secretion assay
Cells were seeded in 12-well plates at 16105 cells per well and
treated with LG or HG for 6 days. They were then washed with
Krebs-Ringer bicarbonate buffer with HEPES and 0.1% BSA
(KRBH) [43] and pre-incubated in KRBH containing 2.8 mM
glucose for 1 h at 37 C. Cells were then incubated in fresh KRBH
containing 2.8 mM glucose for 1 h at 37 C (basal secretion),
followed by KRBH containing 16.7 mM glucose for 1 h at 37 C
(stimulated secretion). The incubation buffers were removed and
insulin was extracted from the attached cells using acid-ethanol.
Insulin in the incubation buffers and cell extracts was quantified
using the rat/mouse insulin ELISA kit (Millipore, Billerica, MA,
USA) according to the manufacturer’s protocol. Insulin secretion
was expressed as a percentage of the total cellular insulin content,
which was the sum of insulin present in the basal and stimulated
secretions as well as in cell extracts.
Figure 7. Inhibition of ERK phosphorylation in ERoSHKHG restored cell-cell contact and colony morphology. a ERoSHK cells were
cultured in LG or HG in the absence and presence of 25 mM of PD98059 for 6 days. Cells were fixed, immunostained for E-cadherin (green) and
counterstained with phalloidin (red) for F-actin and DAPI (blue) for nuclei. White arrowheads indicate sites of membrane separation. Parts of the
merged image (box with white dashed lines) are magnified in the right panels to clearly visualize the co-localization of E-cadherin and cortical actin
along the cell periphery, as well as gaps between adjacent cells. Scale bars, 10 mm. b Representative phase contrast images of ERoSHKLG and
ERoSHKHG treated with or without PD98059 to show changes in colony morphology. Scale bars, 100 mm. c ERoSHKLG and ERoSHKHG treated with or
without PD98059 were stained with phycoerythrin-conjugated Annexin V and dye fluorescence was measured by flow cytometry. Percentages of
Annexin V-positive cells are assessed and graphically represented. Data are presented as mean 6 s.d.; n = 3. d Insulin secretion of ERoSHKLG and
ERoSHKHG treated with or without PD98059 in response to 2.8 mM (basal) and 16.7 mM (stimulated) glucose, expressed as a percentage of total
insulin content. Data are presented as mean 6 s.d.; n = 3. *, P,0.05; **, P,0.005; ***, P,0.001.
doi:10.1371/journal.pone.0044988.g007
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Oligonucleotide microarray
Cells were treated with LG or HG for 6 days. Total RNA from
the samples was extracted using the Nucleospin RNA/protein kit
(Macherey-Nagel, Du¨ren, Germany). 500 ng of total RNA from
each of the biological triplicates of LG or HG-treated cells was
reverse transcribed into cDNA, amplified to generate biotinylated
cRNA and purified using the Illumina TotalPrep RNA amplifi-
cation kit (Ambion Inc., Austin, TX, USA) according to the
manufacturer’s protocol. Hybridization to the Illumina MouseRef-
8 v2.0 Expression BeadChip (Illumina Inc., San Diego, CA, USA),
washing and scanning were performed according to the Illumina
BeadStation 5006 manual. Data were extracted and average
normalization and background subtraction was performed using
Illumina BeadStudio Gene Expression Module v3 provided by the
manufacturer. Transcript signals below the limit of detection of
95% confidence were defined as genes unexpressed, and an
expression fold change criteria of 2.0 was used to determine up- or
down-regulation of genes. Gene datasets were uploaded onto
Ingenuity Pathway Analysis platform (Ingenuity Systems, Moun-
tain View, CA, USA) for functional clustering. Gene expression
changes were validated by analyzing expression levels of randomly
selected genes using quantitative PCR (qPCR). Briefly, 1 mg of
RNA was converted to cDNA using random primers in a 20-ml
reaction volume using a High Capacity cDNA Archive Kit
(Applied Biosystems, Foster City, CA, USA). A 20 ml qPCR
reaction mixture was set up to contain 20 ng of cDNA in a 3-ml
volume, 250 nM of both forward and reverse primers in a 2-ml
volume, 5 ml of nuclease-free water and 10 ml of 26SYBR Green
PCR Master Mix (Applied Biosystems). Amplification was
performed on ABI StepOne Plus Real Time PCR System (Applied
Biosystems). Relative transcript levels were calculated based on
comparative changes in cycle threshold values, with Actb as the
endogenous control. Primer sequences are listed in Table S1.
Total viable cell count
Cells were seeded in 24-well plates at 26105 cells per well and
treated with LG or HG. At each indicated timepoint, triplicate
wells in each treatment group were trypsinized into single-cells and
total viable cell number was counted using the Guava ViaCount
assay on a Guava Personal Cell Analysis-96 system (Guava
Technologies, Hayward, CA, USA).
Cell cycle analysis
Cells were treated with LG or HG for 6 days and cell cycle
analyses were performed at the indicated timepoints for a period of
72 h thereafter. At each timepoint, they were harvested by
trypsinization into single-cells. 56105 cells were washed and fixed
in 70% ethanol at 220 C overnight. They were then collected by
centrifugation, resuspended in PBS containing 5 mg/ml RNase,
DNase-free (Roche Applied Science Inc., Penzberg, Upper
Bavaria, Germany) and 0.05% Triton X-100 and incubated for
2 h at 37 C with rotation. Subsequently, propidium iodide was
added to a final concentration of 50 mg/ml and DNA content of
the cells was measured using the BD FACSCalibur flow cytometer
(BD Biosciences, Franklin Lakes, NJ, USA). Histograms were
deconvoluted using the ModFit LT v3.2 software (Verity Software
House, Topsham, ME, USA).
Cell division assay
Cells were subjected to LG or HG treatment for 6 days,
trypsinized into single-cells and incubated with 5 mM of carboxy-
fluorescein diacetate, succinimidyl ester (CFSE, Invitrogen) for
15 min at 37 C. They were washed to remove excess dye,
resuspended in INS medium containing 2 or 6 g/l glucose and
plated at a density of 16106 cells per well in 6-well plates. Cells
were then harvested at the indicated timepoints (0–72 h post
CFSE-staining), fixed in 2% paraformaldehyde and the median
fluorescence intensity of the cells was measured using the BD
FACSCalibur flow cytometer (BD Biosciences). The number of
cell divisions (n) at each timepoint was calculated as described in
[52]. Briefly, n= (lg F0/Fn)/lg 2 where F0 is the initial average
cellular fluorescence and Fn is the average cellular fluorescence at
each timepoint. When time (h) was plotted against n, the gradient
of the linear graph represents the duration of one cell division (h).
Annexin V assay
Cells were subjected to LG or HG treatment for 6 days and
Annexin V assays were performed at the indicated timepoints for a
period of 72 h thereafter. At each timepoint, they were harvested
by trypsinization into single-cells. 26105 cells were washed and
stained using the Annexin V-PE Apoptosis Detection Kit (Merck,
KGaA, Darmstadt, Germany) according to the manufacturer’s
protocol. The percentage of Annexin V-positive cells was
quantified on the BD FACSCalibur flow cytometer (BD Biosci-
ences).
Immunocytochemistry
Cells were seeded onto 20620 mm glass coverslips, subjected to
LG or HG treatment for 6 days, fixed with 4% paraformaldehyde
for 15 min and then permeabilized with 0.1% Triton X-100 for
3 min. The cells were then incubated with 4% normal goat serum
for 30 min to block non-specific binding sites, and then incubated
with 1:100 diluted purified mouse anti-vinculin monoclonal IgG1
clone 7F9 (Millipore) or purified mouse anti-E-cadherin mono-
clonal IgG2a clone 36 (BD Biosciences) at 4 C overnight. Cells
were subsequently washed and incubated with 1:500 diluted Alexa
Fluor 488-conjugated goat anti-mouse IgG antibodies (Invitrogen,
Carlsbad, CA, USA) and 1:500 diluted rhodamine-conjugated
phalloidin (Millipore) for 1 h. They were then washed, counter-
stained with DAPI, mounted and visualized using a Zeiss LSM
510 laser scanning confocal microscope (Carl Zeiss, Inc.,
Oberkochen, Germany).
ERK phosphorylation assay
Serum starvation was performed by incubating cells in KRBH
containing 2.8 mM glucose. Cultured cells were washed with PBS
twice and proteins were extracted using the Mammalian Cell
Extraction Kit (BioVision, Mountain View, CA, USA) supple-
mented with Phosphatase Inhibitor Cocktail 3 (Sigma-Aldrich, St.
Louis, MO, USA) according to the manufacturer’s protocol. Total
protein amount was measured using the Bio-Rad Protein Assay
(Bio-Rad, Hercules, CA, USA). The proteins were electroblotted
onto a nitrocellulose membrane after first separating on a 4–12%
SDS–polyacrylamide gel. The membrane was blocked with
StartingBlock T20 (PBS) Blocking Buffer (Thermo Fisher Scien-
tific, Rockford, IL, USA) for 30 min at room temperature and
incubated with 1:1000 diluted purified rabbit anti-phospho-
ERK1/2 (Thr202/Tyr204) polyclonal IgG (Cell Signaling Tech-
nology, Danvers, MA, USA). The blot was then washed and
incubated with a horseradish peroxidase-conjugated 1:5000
diluted goat anti-rabbit IgG (Santa Cruz Biotechnology, Santa
Cruz, CA, USA). The blot was then washed and incubated with
HRP-enhanced chemiluminescent substrate (Thermo Fisher
Scientific) and exposed to an X-ray film. To probe for total
ERK1/2, bound antibodies were stripped off the blot by
incubating it in Restore Western Blot Stripping Buffer (Thermo
Fisher Scientific) for 5 min at room temperature. A second western
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blot was performed using 1:1000 diluted purified rabbit anti-
ERK1/2 polyclonal IgG clone K-23 (Santa Cruz Biotechnology)
as primary antibodies instead. Intensities of protein bands were
quantified by densitometry using ImageJ version 1.44d (NIH,
USA).
Statistical analyses
Statistical significance between two samples was determined
using unpaired Student’s t tests, with P,0.05 as the level of
significance.
Supporting Information
Figure S1 Cell division rate of ERoSHKLG and
ERoSHKHG. ERoSHK cells pretreated with LG and HG for 6
days were stained with CFSE and the rate of loss of fluorescence
signal was monitored over 72 h by flow cytometry. Duration of
cell division can be calculated based on the gradient of the best-fit
line of the time versus n scatter plot, where n is the number of cell
divisions at each timepoint (see Materials and Methods).
(TIF)
Figure S2 Inhibition of ERK1/2 signaling did not
reduce apoptosis in ERoSHKHG. ERoSHK cells were treated
with LG and HG in combination with various concentrations of
the ERK1/2 inhibitor PD98059 for 6 days. The cells were then
stained with phycoerythrin-conjugated Annexin V and dye
fluorescence was measured by flow cytometry. Percentages of
Annexin V-positive cells are assessed and graphically represented.
Data are presented as mean 6 s.d.; n = 3.
(TIF)
Table S1 Primer sequences for qPCR.
(DOCX)
Table S2 List of genes upregulated by .2.0 fold in
ERoSHKHG
(XLS)
Table S3 Genes clustered into each of the top 5 most
significant cellular processes in ERoSHKHG
(XLSX)
Author Contributions
Conceived and designed the experiments: SKL RWYY. Performed the
experiments: RWYY KY. Analyzed the data: SKL RWYY KY GL. Wrote
the paper: SKL RWYY GL.
References
1. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003) The
metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
Diabetes Care 26: 3153–3159.
2. Brownlee M (2005) The pathobiology of diabetic complications: a unifying
mechanism. Diabetes 54: 1615–1625.
3. UKPDS (1998) Intensive blood-glucose control with sulphonylureas or insulin
compared with conventional treatment and risk of complications in patients with
type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet 352: 837–853.
4. UKPDS (1998) Effect of intensive blood-glucose control with metformin on
complications in overweight patients with type 2 diabetes (UKPDS 34). UK
Prospective Diabetes Study (UKPDS) Group. Lancet 352: 854–865.
5. Holman RR (1998) Assessing the potential for alpha-glucosidase inhibitors in
prediabetic states. Diabetes Res Clin Pract 40 Suppl: S21–25.
6. Wajchenberg BL (2007) beta-cell failure in diabetes and preservation by clinical
treatment. Endocr Rev 28: 187–218.
7. Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular
pathways of disease. Exp Mol Pathol 83: 84–92.
8. Malhotra JD, Miao H, Zhang K, Wolfson A, Pennathur S, et al. (2008)
Antioxidants reduce endoplasmic reticulum stress and improve protein secretion.
Proc Natl Acad Sci U S A 105: 18525–18530.
9. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS (2004) Calcium,
ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol
287: C817–833.
10. Buchanan TA (2003) Pancreatic beta-cell loss and preservation in type 2
diabetes. Clin Ther 25 Suppl B: B32–46.
11. DeFronzo RA (2004) Pathogenesis of type 2 diabetes mellitus. Med Clin North
Am 88: 787–835, ix.
12. Kahn SE (2001) Clinical review 135: The importance of beta-cell failure in the
development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:
4047–4058.
13. Patane G, Anello M, Piro S, Vigneri R, Purrello F, et al. (2002) Role of ATP
production and uncoupling protein-2 in the insulin secretory defect induced by
chronic exposure to high glucose or free fatty acids and effects of peroxisome
proliferator-activated receptor-gamma inhibition. Diabetes 51: 2749–2756.
14. Olson LK, Redmon JB, Towle HC, Robertson RP (1993) Chronic exposure of
HIT cells to high glucose concentrations paradoxically decreases insulin gene
transcription and alters binding of insulin gene regulatory protein. J Clin Invest
92: 514–519.
15. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, et al. (2003) Beta-cell
deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Diabetes 52: 102–110.
16. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, et al. (2001)
Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the
rise in net cell death. Diabetes 50: 1021–1029.
17. Andreozzi F, D’Alessandris C, Federici M, Laratta E, Del Guerra S, et al. (2004)
Activation of the hexosamine pathway leads to phosphorylation of insulin
receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol
3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in
RIN pancreatic beta-cells. Endocrinology 145: 2845–2857.
18. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of
insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2
diabetes mellitus. J Clin Invest 104: 787–794.
19. Marchetti P, Dotta F, Lauro D, Purrello F (2008) An overview of pancreatic
beta-cell defects in human type 2 diabetes: implications for treatment. Regul
Pept 146: 4–11.
20. Stolar M (2010) Glycemic control and complications in type 2 diabetes mellitus.
Am J Med 123: S3–11.
21. Li G, Luo R, Zhang J, Yeo KS, Lian Q, et al. (2009) Generating mESC-derived
insulin-producing cell lines through an intermediate lineage-restricted progenitor
line. Stem Cell Res 2: 41–55.
22. Chen TS, Tan SS, Yeo RW, Teh BJ, Luo R, et al. (2010) Delineating biological
pathways unique to embryonic stem cell-derived insulin-producing cell lines
from their noninsulin-producing progenitor cell lines. Endocrinology 151: 3600–
3610.
23. Malaisse WJ, Malaisse-Lagae F, Walker MO, Lacy PE (1971) The stimulus-
secretion coupling of glucose-induced insulin release. V. The participation of a
microtubular-microfilamentous system. Diabetes 20: 257–265.
24. Orci L, Gabbay KH, Malaisse WJ (1972) Pancreatic beta-cell web: its possible
role in insulin secretion. Science 175: 1128–1130.
25. Howell SL, Tyhurst M (1986) The cytoskeleton and insulin secretion. Diabetes
Metab Rev 2: 107–123.
26. Seino S, Shibasaki T, Minami K (2011) Dynamics of insulin secretion and the
clinical implications for obesity and diabetes. J Clin Invest 121: 2118–2125.
27. Tsuboi T, Rutter GA (2003) Insulin secretion by ‘kiss-and-run’ exocytosis in
clonal pancreatic islet beta-cells. Biochem Soc Trans 31: 833–836.
28. Eliasson L, Abdulkader F, Braun M, Galvanovskis J, Hoppa MB, et al. (2008)
Novel aspects of the molecular mechanisms controlling insulin secretion.
J Physiol 586: 3313–3324.
29. Burgoyne RD (1990) Secretory vesicle-associated proteins and their role in
exocytosis. Annu Rev Physiol 52: 647–659.
30. Wilson JR, Ludowyke RI, Biden TJ (2001) A redistribution of actin and myosin
IIA accompanies Ca(2+)-dependent insulin secretion. FEBS Lett 492: 101–106.
31. Tomas A, Yermen B, Min L, Pessin JE, Halban PA (2006) Regulation of
pancreatic beta-cell insulin secretion by actin cytoskeleton remodelling: role of
gelsolin and cooperation with the MAPK signalling pathway. J Cell Sci 119:
2156–2167.
32. Wang Z, Thurmond DC (2010) Differential phosphorylation of RhoGDI
mediates the distinct cycling of Cdc42 and Rac1 to regulate second-phase insulin
secretion. J Biol Chem 285: 6186–6197.
33. Malacombe M, Bader MF, Gasman S (2006) Exocytosis in neuroendocrine cells:
new tasks for actin. Biochim Biophys Acta 1763: 1175–1183.
34. Gourlay CW, Ayscough KR (2005) The actin cytoskeleton: a key regulator of
apoptosis and ageing? Nat Rev Mol Cell Biol 6: 583–589.
35. Rondas D, Tomas A, Halban PA (2011) Focal adhesion remodeling is crucial for
glucose-stimulated insulin secretion and involves activation of focal adhesion
kinase and paxillin. Diabetes 60: 1146–1157.
Glucotoxicity Inhibits Cytoskeletal Dynamism
PLOS ONE | www.plosone.org 13 September 2012 | Volume 7 | Issue 9 | e44988
36. Wang JL, Easom RA, Hughes JH, McDaniel ML (1990) Evidence for a role of
microfilaments in insulin release from purified beta-cells. Biochem Biophys Res
Commun 171: 424–430.
37. Howell SL, Tyhurst M (1979) Interaction between insulin-storage granules and
F-actin in vitro. Biochem J 178: 367–371.
38. Snabes MC, Boyd AE, 3rd (1982) Increased filamentous actin in islets of
Langerhans from fasted hamsters. Biochem Biophys Res Commun 104: 207–
211.
39. Swanston-Flatt SK, Carlsson L, Gylfe E (1980) Actin filament formation in
pancreatic beta-cells during glucose stimulation of insulin secretion. FEBS Lett
117: 299–302.
40. Jewell JL, Luo W, Oh E, Wang Z, Thurmond DC (2008) Filamentous actin
regulates insulin exocytosis through direct interaction with Syntaxin 4. J Biol
Chem 283: 10716–10726.
41. Wang Z, Thurmond DC (2009) Mechanisms of biphasic insulin-granule
exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins.
J Cell Sci 122: 893–903.
42. Kowluru A (2010) Small G proteins in islet beta-cell function. Endocr Rev 31:
52–78.
43. Li J, Luo R, Kowluru A, Li G (2004) Novel regulation by Rac1 of glucose- and
forskolin-induced insulin secretion in INS-1 beta-cells. Am J Physiol Endocrinol
Metab 286: E818–827.
44. Thurmond DC, Gonelle-Gispert C, Furukawa M, Halban PA, Pessin JE (2003)
Glucose-stimulated insulin secretion is coupled to the interaction of actin with
the t-SNARE (target membrane soluble N-ethylmaleimide-sensitive factor
attachment protein receptor protein) complex. Mol Endocrinol 17: 732–742.
45. Maedler K, Størling J, Sturis J, Zuellig RA, Spinas GA, et al. (2004) Glucose-
and Interleukin-1b-Induced b-Cell Apoptosis Requires Ca2+ Influx and
Extracellular Signal-Regulated Kinase (ERK) 1/2 Activation and Is Prevented
by a Sulfonylurea Receptor 1/Inwardly Rectifying K+ Channel 6.2 (SUR/
Kir6.2) Selective Potassium Channel Opener in Human Islets. Diabetes 53:
1706–1713.
46. Wijesekara N, Krishnamurthy M, Bhattacharjee A, Suhail A, Sweeney G, et al.
(2010) Adiponectin-induced ERK and Akt Phosphorylation Protects against
Pancreatic Beta Cell Apoptosis and Increases Insulin Gene Expression and
Secretion. Journal of Biological Chemistry 285: 33623–33631.
47. Alejandro EU, Kalynyak TB, Taghizadeh F, Gwiazda KS, Rawstron EK, et al.
(2010) Acute Insulin Signaling in Pancreatic Beta-Cells Is Mediated by Multiple
Raf-1 Dependent Pathways. Endocrinology 151: 502–512.
48. Hauge-Evans AC, Squires PE, Persaud SJ, Jones PM (1999) Pancreatic beta-cell-
to-beta-cell interactions are required for integrated responses to nutrient stimuli:
enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes
48: 1402–1408.
49. Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ (2003) Differential
activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-
cells. Diabetes 52: 974–983.
50. Frodin M, Sekine N, Roche E, Filloux C, Prentki M, et al. (1995) Glucose, other
secretagogues, and nerve growth factor stimulate mitogen-activated protein
kinase in the insulin-secreting beta-cell line, INS-1. J Biol Chem 270: 7882–
7889.
51. Longuet C, Broca C, Costes S, Hani EH, Bataille D, et al. (2005) Extracellularly
regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate
synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of
Langerhans. Endocrinology 146: 643–654.
52. Kowluru A, Veluthakal R, Rhodes CJ, Kamath V, Syed I, et al. (2010) Protein
farnesylation-dependent Raf/extracellular signal-related kinase signaling links to
cytoskeletal remodeling to facilitate glucose-induced insulin secretion in
pancreatic beta-cells. Diabetes 59: 967–977.
53. Papoutsopoulou S, Symons A, Tharmalingham T, Belich MP, Kaiser F, et al.
(2006) ABIN-2 is required for optimal activation of Erk MAP kinase in innate
immune responses. Nat Immunol 7: 606–615.
54. Pang L, Sawada T, Decker SJ, Saltiel AR (1995) Inhibition of MAP kinase
kinase blocks the differentiation of PC-12 cells induced by nerve growth factor.
J Biol Chem 270: 13585–13588.
55. Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and
metabolic mechanisms of insulin resistance and beta-cell failure in type 2
diabetes. Nat Rev Mol Cell Biol 9: 193–205.
56. Skyler JS (2004) Effects of glycemic control on diabetes complications and on the
prevention of diabetes. Clinical Diabetes 22: 162–166.
57. Haffner SM, Miettinen H, Gaskill SP, Stern MP (1996) Decreased insulin action
and insulin secretion predict the development of impaired glucose tolerance.
Diabetologia 39: 1201–1207.
58. Pratley RE, Weyer C (2002) Progression from IGT to type 2 diabetes mellitus:
the central role of impaired early insulin secretion. Curr Diab Rep 2: 242–248.
59. Leahy JL (2004) Detrimental Effects of Chronic Hyperglycemia on the
Pancreatic Beta-Cell. In: LeRoith D, Taylor SI, Olefsky JM, editors. Diabetes
Mellitus: A Fundamental and Clinical Text. 3rd ed. Philadelphia: Lippincott
Williams & Wilkins. pp. xviii, 1540 p.
60. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, et al. (1976)
Relationships between fasting plasma glucose levels and insulin secretion during
intravenous glucose tolerance tests. J Clin Endocrinol Metab 42: 222–229.
61. Carver TD, Anderson SM, Aldoretta PA, Esler AL, Hay WW, Jr. (1995)
Glucose suppression of insulin secretion in chronically hyperglycemic fetal sheep.
Pediatr Res 38: 754–762.
62. Rossetti L, Shulman GI, Zawalich W, DeFronzo RA (1987) Effect of chronic
hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
J Clin Invest 80: 1037–1044.
63. Chen J, Jeppesen PB, Nordentoft I, Hermansen K (2007) Stevioside improves
pancreatic beta-cell function during glucotoxicity via regulation of acetyl-CoA
carboxylase. Am J Physiol Endocrinol Metab 292: E1906–1916.
64. Khaldi MZ, Guiot Y, Gilon P, Henquin JC, Jonas JC (2004) Increased glucose
sensitivity of both triggering and amplifying pathways of insulin secretion in rat
islets cultured for 1 wk in high glucose. Am J Physiol Endocrinol Metab 287:
E207–217.
65. Maris M, Ferreira GB, D’Hertog W, Cnop M, Waelkens E, et al. (2010) High
glucose induces dysfunction in insulin secretory cells by different pathways: a
proteomic approach. J Proteome Res 9: 6274–6287.
66. Nyblom HK, Thorn K, Ahmed M, Bergsten P (2006) Mitochondrial protein
patterns correlating with impaired insulin secretion from INS-1E cells exposed to
elevated glucose concentrations. Proteomics 6: 5193–5198.
67. Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, et al. (2001) High
glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a
potential role for regulation of specific Bcl family genes toward an apoptotic cell
death program. Diabetes 50: 1290–1301.
68. Fei H, Zhao B, Zhao S, Wang Q (2008) Requirements of calcium fluxes and
ERK kinase activation for glucose- and interleukin-1beta-induced beta-cell
apoptosis. Mol Cell Biochem 315: 75–84.
69. McKenzie MD, Jamieson E, Jansen ES, Scott CL, Huang DC, et al. (2010)
Glucose induces pancreatic islet cell apoptosis that requires the BH3-only
proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 59: 644–
652.
70. Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, et al. (2004) Structural
and functional abnormalities in the islets isolated from type 2 diabetic subjects.
Diabetes 53: 624–632.
71. Dahl U, Sjodin A, Semb H (1996) Cadherins regulate aggregation of pancreatic
beta-cells in vivo. Development 122: 2895–2902.
72. Inoguchi T, Ueda F, Umeda F, Yamashita T, Nawata H (1995) Inhibition of
intercellular communication via gap junction in cultured aortic endothelial cells
by elevated glucose and phorbol ester. Biochem Biophys Res Commun 208:
492–497.
73. Kuroki T, Inoguchi T, Umeda F, Ueda F, Nawata H (1998) High glucose
induces alteration of gap junction permeability and phosphorylation of
connexin-43 in cultured aortic smooth muscle cells. Diabetes 47: 931–936.
74. Li AF, Sato T, Haimovici R, Okamoto T, Roy S (2003) High glucose alters
connexin 43 expression and gap junction intercellular communication activity in
retinal pericytes. Invest Ophthalmol Vis Sci 44: 5376–5382.
75. Oku H, Kodama T, Sakagami K, Puro DG (2001) Diabetes-induced disruption
of gap junction pathways within the retinal microvasculature. Invest Ophthalmol
Vis Sci 42: 1915–1920.
76. Sato T, Haimovici R, Kao R, Li AF, Roy S (2002) Downregulation of connexin
43 expression by high glucose reduces gap junction activity in microvascular
endothelial cells. Diabetes 51: 1565–1571.
77. Stalmans P, Himpens B (1997) Effect of increasing glucose concentrations and
protein phosphorylation on intercellular communication in cultured rat retinal
pigment epithelial cells. Invest Ophthalmol Vis Sci 38: 1598–1609.
78. Gandhi GK, Ball KK, Cruz NF, Dienel GA (2010) Hyperglycaemia and
diabetes impair gap junctional communication among astrocytes. ASN Neuro 2:
e00030.
79. Jaques F, Jousset H, Tomas A, Prost AL, Wollheim CB, et al. (2008) Dual effect
of cell-cell contact disruption on cytosolic calcium and insulin secretion.
Endocrinology 149: 2494–2505.
80. Eddlestone GT, Goncalves A, Bangham JA, Rojas E (1984) Electrical coupling
between cells in islets of Langerhans from mouse. J Membr Biol 77: 1–14.
81. Moreno AP, Berthoud VM, Perez-Palacios G, Perez-Armendariz EM (2005)
Biophysical evidence that connexin-36 forms functional gap junction channels
between pancreatic mouse beta-cells. Am J Physiol Endocrinol Metab 288:
E948–956.
82. Michon L, Nlend Nlend R, Bavamian S, Bischoff L, Boucard N, et al. (2005)
Involvement of gap junctional communication in secretion. Biochim Biophys
Acta 1719: 82–101.
83. Charollais A, Gjinovci A, Huarte J, Bauquis J, Nadal A, et al. (2000) Junctional
communication of pancreatic beta cells contributes to the control of insulin
secretion and glucose tolerance. J Clin Invest 106: 235–243.
84. Hayden MR, Patel K, Habibi J, Gupta D, Tekwani SS, et al. (2008) Attenuation
of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic
extracellular matrix ultrastructural abnormalities. J Cardiometab Syndr 3: 234–
243.
85. Hayden MR, Sowers JR (2007) Isletopathy in Type 2 diabetes mellitus:
implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative
stress. Antioxid Redox Signal 9: 891–910.
86. Ritzel RA, Meier JJ, Lin CY, Veldhuis JD, Butler PC (2007) Human islet
amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and
impair insulin secretion in isolated human islets. Diabetes 56: 65–71.
87. Hayden MR, Karuparthi PR, Habibi J, Lastra G, Patel K, et al. (2008)
Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface
in the HIP rat model of diabetes. Exp Biol Med (Maywood) 233: 1109–1123.
88. Costes S, Broca C, Bertrand G, Lajoix AD, Bataille D, et al. (2006) ERK1/2
control phosphorylation and protein level of cAMP-responsive element-binding
Glucotoxicity Inhibits Cytoskeletal Dynamism
PLOS ONE | www.plosone.org 14 September 2012 | Volume 7 | Issue 9 | e44988
protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes 55:
2220–2230.
89. Jacobo SM, Guerra ML, Hockerman GH (2009) Cav1.2 and Cav1.3 are
differentially coupled to glucagon-like peptide-1 potentiation of glucose-
stimulated insulin secretion in the pancreatic beta-cell line INS-1. J Pharmacol
Exp Ther 331: 724–732.
90. Koffer A, Tatham PE, Gomperts BD (1990) Changes in the state of actin during
the exocytotic reaction of permeabilized rat mast cells. J Cell Biol 111: 919–927.
91. Rose SD, Lejen T, Zhang L, Trifaro JM (2001) Chromaffin cell F-actin
disassembly and potentiation of catecholamine release in response to protein
kinase C activation by phorbol esters is mediated through myristoylated alanine-
rich C kinase substrate phosphorylation. J Biol Chem 276: 36757–36763.
92. Jewell JL, Oh E, Thurmond DC (2010) Exocytosis mechanisms underlying
insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4.
Am J Physiol Regul Integr Comp Physiol 298: R517–531.
Glucotoxicity Inhibits Cytoskeletal Dynamism
PLOS ONE | www.plosone.org 15 September 2012 | Volume 7 | Issue 9 | e44988
